Literature DB >> 15853695

Prion disease: a deadly disease for protein misfolding.

Chiranjib Chakraborty1, Shyam Nandi, Snehasis Jana.   

Abstract

An infectious particle, termed prion, composed largely and perhaps solely of a single protein, is the likely causative agent of prion disease. It produces lethal decline of cognitive and motor function. The responsible protein arrives at a pathogenic state by misfolding from a normal form that has ubiquitous tissue distribution. Prion diseases are often called spongiform encephalopathies. Probably most mammalian species develop these diseases. Specific examples in various animals are -Scrapie, Transmissible Mink Encephalopathy (TME ), Chronic Wasting Disease(CWD) and bovine spongiform encephalopathy (BSE). Humans are also susceptible to several prion diseases: Creutzfeld-Jacob Disease (CJD), Gerstmann-Straussler-Scheinker Syndrome (GSS), Fatal Familial Insomnia (FFI), Kuru and Alpers Syndrome. This paper reviews transmission of this diseases, protein involvement, nature of protein, the conversion process from PrP(c) to PrP(Sc), conversion of prion protein in vitro, the different proposed models for the conversion of PrP(c) to PrP(Sc), prion and other amyloid diseases, prion strains, structure of PrP(c) the particular process that may induce prion disease, and immunization against these diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853695     DOI: 10.2174/1389201053642321

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  Amyloid formation in denatured single-mutant lysozymes where residual structures are modulated.

Authors:  Tomonori Mishima; Takatoshi Ohkuri; Akira Monji; Taiji Imoto; Tadashi Ueda
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

Review 2.  Senescence suppressors: their practical importance in replicative lifespan extension in stem cells.

Authors:  Eun Seong Hwang
Journal:  Cell Mol Life Sci       Date:  2014-07-23       Impact factor: 9.261

Review 3.  Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis.

Authors:  Gaurav Pandey; Vibin Ramakrishnan
Journal:  Biophys Rev       Date:  2020-09-15

4.  Analysis of core region from egg white lysozyme forming amyloid fibrils.

Authors:  Yuhei Tokunaga; Yukako Sakakibara; Yoshiki Kamada; Kei-ichi Watanabe; Yasushi Sugimoto
Journal:  Int J Biol Sci       Date:  2013-02-13       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.